Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.

On the occasion of World Hemophilia Day, let us reflect on this disorder and examine the current state of treatment for ...

Even though it is a rare condition, awareness about hemophilia is necessary to manage the condition. Read on to know about ...

For U.S. patients with severe hemophilia A, prophylaxis with efanesoctocog alfa is neither conventionally nor ...

Hemophilia impairs the body's capacity to form blood clots, a process essential for haemostasis following bleeding. This ...

Perspectives from Martin Nielsen, Denmark, who lives with hemophilia B, and Wolfgang Miesbach, professor of medicine at ...

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial ...

Observed on April 17, World Hemophilia Day aims to spread awareness regarding the challenges faced by those living with ...

With this year's theme "Access for All: Women and Girls Bleed Too," experts stress that bleeding disorders are not just a man ...

Hemophilia, a rare inherited bleeding disorder, is primarily caused by mutations in specific genes that impair the body’s ...

According to estimates by the World Federation of Hemophilia, nearly 80% of hemophilia cases in India remain undiagnosed, ...

HEMLIBRA has strong market potential due to its unique, subcutaneous prophylactic treatment for Hemophilia A, including ...